Mycobacterium avium infection in CD14-deficient mice fails to substantiate a significant role for CD14 in antimycobacterial protection or granulomatous inflammation

Immunology

Volumn 103, Issue 1, 2001, Pages 113-121

  Ehlers, Stefan ^a   Reiling, Norbert ^a   Gangloff, Sophie ^b   Woltmann, Alexander ^c   Goyert, Sanna ^b  

^a RESEARCH CENTER BORSTEL   (Germany)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON; MESSENGER RNA; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GRANULOMATOUS INFLAMMATION; IN VITRO STUDY; MOUSE; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; PROTECTION;

ANIMALS; ANTIGENS, CD14; BONE MARROW; CELL CULTURE TECHNIQUES; CYTOKINES; FEMALE; GRANULOMA; LIVER; MACROPHAGES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INFECTIONS; RNA, MESSENGER;

EID: 0035014399     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2001.01214.x     Document Type: Article

References (39)

1. Bazil V, Baudys M, Hilgert I, Stefanova I, Low MG, Zbrozek J, Horejsi V. Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein, CD14. Mol Immunol 1989; 26:657-62.
2. Goyert SM, Ferrero E, Rettig WJ, Yenamandra AI, Obata F, Le Beau MM. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 1988; 239:497-500.
3. Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 1988; 141:547-52.
4. Dziarski R, Ulmer AJ, Gupta D. Interactions of CD14 with components of Gram-positive bacteria. Chem Immunol 2000; 74:83-107.
5. Gupta D, Kirkland TN, Viriyakosol S, Dziarski R. CD14 is a cell-activating receptor for bacterial peptidoglycan. J Biol Chem 1996; 271:23310-6.
6. Ulmer AJ, Dziarski R, El-Samalouti V, Rietschel ET, Flad HD. CD14, an innate immune receptor for various bacterial cell wall components. In: Brade H, Opal SM, Vogel SN, Morrison DC, eds. Endotoxin in Health and Disease. New York: Marcel Dekker, 1999:463-75.
7. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of LPS and LPS binding protein. Science 1990; 249:1431-3.
8. Pugin JI, Heumann D, Tomasz A et al. CD14 is a pattern recognition receptor. Immunity 1994; 1:509-16.
9. Lien E, Sellati TJ, Yoshimura A et al. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 1999; 274:33419-25.
10. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999; 163:3920-7.
11. Ferrero E, Jiao D, Tsuberi BZ, Tesio L, Rong GW, Haziot A, Goyert SM. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA 1993; 90:2380-4.
12. Haziot A, Ferrero E, Köntgen F, Hijiy N, Yamamoto S, Silver J, Stewart CL, Goyert SM. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4:407-14.
13. Sellati T, Bouis DA, Kitchens RL et al. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. J Immunol 1998; 160:5455-64.
14. van Furth AM, Verhard-Seijmonsbergen EM, Langermans JA, van Dissel JT, van Furth R. Anti-CD14 monoclonal antibodies inhibit the production of tumor necrosis factor alpha and interleukin-10 by human monocytes stimulated with killed and live Haemophilus influenzae or Streptococcus pneumoniae organisms. Infect Immun 1999; 67:3714-8.
15. Weidemann B, Brade H, Rietschel ET, Dziarski R, Bazil V, Kusumoto S, Flad HD, Ulmer AJ. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immun 1994; 62:4709-15.
16. Haziot A, Hijiya N, Schultz K, Zhang F, Gangloff SC, Goyert SM. CD14 plays no major role in shock induced by Staphylococcus aureus but down-regulates TNF-alpha production. J Immunol 1999; 162:4801-5.
17. Bernardo J, Billinglea AM, Blumenthal RL, Seetoo KF, Simons ER, Fenton MJ. Differential responses of human mononuclear phagocytes to mycobacterial lipoarabinomannan: role of CD14 and the mannose receptor. Infect Immun 1998; 66:28-35.
18. Zhang Y, Doerfler M, Lee TC, Guillemin B, Rom WN. Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components. J Clin Invest 1993; 91:2076-83.
19. Inderlied CB, Kemper CA, Bermudez LE. The Mycobacterium avium complex. Clin Microbiol Rev 1993; 6:266-310.
20. + T cells. Int Immunol 1996; 8:1299-310.
21. Pedrosa J, Florido M, Kunze ZM, Castro AG, Portaels F, McFadden J, Silva MT, Appelberg R. Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice. Clin Exp Immunol 1994; 98:210-6.
22. Benini J, Ehlers EM, Ehlers S. Different types of pulmonary granuloma necrosis in immunocompetent vs. TNFRp55-gene-deficient mice aerogenically infected with highly virulent Mycobacterium avium. J Pathol 1999; 188:127-37.
23. Flynn JL, Goldstein MM, Chan J et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995; 2:561-72.
24. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989; 56:731-40.
25. Appelberg R, Castro AG, Pedrosa J, Silva RA, Orme IM, Minoprio P. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect Immun 1994; 62:3962-70.
26. Smith DA, Hänsch HCR, Bancroft GJ, Ehlers S. T-cell-independent granuloma formation in response to Mycobacterium avium - role of tumour necrosis factor alpha and interferon gamma. Immunology 1997; 92:413-21.
27. Gangloff SC, Hijiya N, Haziot A, Goyert SM. Lipopolysaccharide structure influences the macrophage response via CD14-independent and CD14-dependent pathways. Clin Infect Dis 1999; 28:491-6.
28. Medina E, Rogerson BJ, North RJ. The Nramp1 antimicrobial resistance gene segregates independently of resistance to virulent Mycobacterium tuberculosis. Immunology 1996; 88:479-81.
29. Ehlers S, Benini J, Kutsch S, Endres R, Rietschel ET, Pfeffer K. Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium. Infect Immun 1999; 67:3571-9.
30. Cattoretti G, Piteri S, Parraricini C et al. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 1993; 171:83-98.
31. Ehlers S, Seitzer U. Measuring immune responses in vivo. In: Kaufmann S, Kabelitz D, eds. Methods in Microbiology, Vol 25. Immunology of Infection. London, UK: Academic Press, 1998:365-87.
32. Sarmento AM, Appelberg R. Relationship between virulence of Mycobacterium avium strains and induction of tumor necrosis factor alpha production in infected mice and in in vitro-cultured mouse macrophages. Infect Immun 1995; 63:3759-64.
33. Geertsma MF, Nibbering PH, Pos O, van Furth R. Interferon-gamma-activated human granulocytes kill ingested Mycobacterium fortuitum more efficiently than normal granulocytes. Eur J Immunol 1990; 20:869-73.
34. Pedrosa J, Saunders BM, Appelberg R, Orme IM, Silva MT, Cooper AM. Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection in mice. Infect Immun 2000; 68:577-83.
35. Woltmann A, Gangloff SC, Bruch HP, Rietschel ET, Solbach W, Silver J, Goyert SM. Reduced bacterial dissemination and liver injury in CD14-deficient mice following a chronic abscess-forming peritnitis induced by Bacteroides fragilis. Med Microbiol Immunol 1998; 187:149-56.
36. Ernst JD. Macrophage receptors for Mycobacterium tuberculosis. Infect Immun 1998; 66:1277-81.
37. Brightbill HD, Libraty DH, Krutzik SR et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999; 285:732-6.
38. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, Aderem A. The toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999; 401:811-5.
39. Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA 1999; 96:14459-63.